Financials
| Half Year Results | Dec. 30, 2022 |
| Annual Report | Aug. 16, 2022 |
| Annual Financial Report | Aug. 16, 2022 |
| Half-year Report | Jan. 26, 2022 |
| Annual Financial Report | Aug. 02, 2021 |
| Half-year Report | Nov. 30, 2020 |
| Final audited results for year ended 31 March 2020 | Aug. 17, 2020 |
Proxies
| Result of AGM | Sep. 07, 2022 |
| Resolutions passed at AGM | Sep. 07, 2022 |
| Notice of AGM | Aug. 19, 2022 |
| Result of AGM | Sep. 27, 2021 |
| Notice of AGM | Sep. 09, 2021 |
| Notice of Results: AGM | Sep. 25, 2020 |
| Notice of AGM | Sep. 09, 2020 |
Ownership Update
| Director Acquires Shares | Mar. 30, 2023 |
| Director acquires shares | Mar. 29, 2023 |
| Director/PDMR Shareholding | Mar. 24, 2023 |
| Director/PDMR Dealings | Mar. 15, 2023 |
| Director/PDMR Shareholding | Nov. 24, 2022 |
| Director/PDMR Shareholding | Jun. 09, 2022 |
| Director/PDMR Shareholding | May. 20, 2022 |
Announcements
| US Registration Statement Effective | Jun. 16, 2023 |
| London Stock Exchange Delisting | May. 22, 2023 |
| ADS Program collapse | May. 19, 2023 |
| Webull Corporate Communications Service Platform | May. 11, 2023 |
| Change of Delisting Date to 22 May 2023 | May. 11, 2023 |
| Result of Meeting | May. 03, 2023 |
| Presentation on OK-101 at ASCRS | May. 03, 2023 |
Prospectuses
| OKYO Pharma Limited - Single prospectus | May. 05, 2021 |
| Issue of convertible loan notes | Sep. 08, 2020 |
| Issue of convertible loan notes | Jul. 28, 2020 |